EarningsQ2 2024 Earnings Report

Brainstorm Cell Therapeutics (GHD) Q2 2024 Earnings Report

1 Followers

DE:GHD Q2 2024 EPS Results

Actual EPS€0.54

Consensus EPS-€0.47

Beat/MissBeat by +€1.00

One Year Ago EPS-€1.74

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2024

Date08/14/2024

TimeBefore Open

Conference CallWednesday, August 14, 2024

DE:GHD Upcoming Earnings

Brainstorm Cell Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

DE:GHD Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 16, 2026	2026 (Q3)	-0.16 / -	-0.169	―
Aug 14, 2026	2026 (Q2)	- / -0.31	-0.303	-2.94% (>-0.01)
May 15, 2026	2026 (Q1)	- / -0.17	-0.401	57.78% (+0.23)
Mar 31, 2026	2025 (Q4)	-0.25 / -0.17	-0.401	57.78% (+0.23)
Nov 14, 2025	2025 (Q3)	-0.33 / -0.17	-0.455	62.75% (+0.29)
Aug 14, 2025	2025 (Q2)	-0.33 / -0.30	0.535	-156.67% (-0.84)
May 16, 2025	2025 (Q1)	- / -0.40	-0.669	40.00% (+0.27)
Mar 31, 2025	2024 (Q4)	-0.87 / -0.40	-0.669	40.00% (+0.27)
Nov 14, 2024	2024 (Q3)	-0.51 / -0.45	-0.401	-13.33% (-0.05)
Aug 14, 2024	2024 (Q2)	-0.47 / 0.54	-1.739	130.77% (+2.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed